Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAL |
| Upstream (Parents) |
|---|
| (<<) CBFA2T3 → MAL |
| (<<) CSTA → MAL |
| (<<) GYPC → MAL |
| (<<) KCTD12 → MAL |
| (<<) KLF2 → MAL |
| (<<) LCP1 → MAL |
| (<<) LTB → MAL |
| (<<) MAPK12 → MAL |
| (<<) NRAS → MAL |
| (<<) NRN1 → MAL |
| (<<) SPDEF → MAL |
| (<<) STAT4 → MAL |
| (<<) TXNIP → MAL |
| Downstream (Children) |
|---|
| MAL → ADRBK1 (>>) |
| MAL → CEND1 (>>) |
| MAL → CLCA4 (>>) |
| MAL → CRNN (>>) |
| MAL → CSF2 (>>) |
| MAL → ERBB3 (>>) |
| MAL → FZD5 (>>) |
| MAL → HNF1A (>>) |
| MAL → IL1F9 (>>) |
| MAL → IVL (>>) |
| MAL → KLK5 (>>) |
| MAL → KRT5 (>>) |
| MAL → SPRR2C (>>) |
| MAL → TMPRSS11D (>>) |
